Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of this study was to examine the effects of delta-tocotrienol (δ-tocotrienol) supplementation on biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease (NAFLD).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Complement Ther Med

Title: Complementary therapies in medicine

Publisher: Elsevier BV

ISSN (Electronic): 1873-6963

ISSN (Print): 0965-2299

Publication date (Electronic): Aug 2020

Volume: 52

Affiliations

[1 ] Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan.

[2 ] Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan. Electronic address: dakhan@cpsp.edu.pk.

[3 ] Armed Forces Institute of Radiology, National University of Medical Sciences, Rawalpindi, Pakistan.

Article

Publisher Item ID: S0965-2299(20)30077-7

DOI: 10.1016/j.ctim.2020.102494

PubMed ID: 32951743

SO-VID: d4723a0f-0ea5-413f-b5d7-1da45801b0dd

History

Keywords: FLI,HOMA-IR,NAFLD;,δ-tocotrienol

Data availability:

Keywords: FLI, HOMA-IR, NAFLD;, δ-tocotrienol

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 16

See all cited by